 Carmen Sucharov
Concepts (379)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MicroRNAs | 22 | 2024 | 668 | 5.340 |
Why?
| | Cardiomyopathy, Dilated | 18 | 2023 | 373 | 4.340 |
Why?
| | Myocytes, Cardiac | 17 | 2021 | 484 | 3.280 |
Why?
| | Myocardium | 12 | 2020 | 981 | 2.260 |
Why?
| | Heart Failure | 16 | 2023 | 2142 | 1.930 |
Why?
| | Circulating MicroRNA | 3 | 2023 | 25 | 1.570 |
Why?
| | Gene Expression Regulation | 14 | 2018 | 2520 | 1.460 |
Why?
| | Ventricular Remodeling | 4 | 2021 | 255 | 1.270 |
Why?
| | Phosphodiesterase 3 Inhibitors | 3 | 2019 | 14 | 1.230 |
Why?
| | Receptors, Adrenergic, beta | 4 | 2016 | 126 | 1.220 |
Why?
| | Heart Ventricles | 13 | 2021 | 778 | 1.200 |
Why?
| | YY1 Transcription Factor | 6 | 2015 | 28 | 1.180 |
Why?
| | Phosphoric Diester Hydrolases | 3 | 2016 | 46 | 1.010 |
Why?
| | Histone Deacetylases | 5 | 2013 | 211 | 0.920 |
Why?
| | Phosphorylation | 9 | 2021 | 1685 | 0.890 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2017 | 116 | 0.870 |
Why?
| | Serum | 3 | 2019 | 57 | 0.860 |
Why?
| | Calcium-Binding Proteins | 4 | 2021 | 213 | 0.850 |
Why?
| | Transcriptome | 5 | 2021 | 871 | 0.840 |
Why?
| | RNA, Messenger | 11 | 2024 | 2700 | 0.830 |
Why?
| | Amniotic Fluid | 2 | 2024 | 79 | 0.780 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2023 | 129 | 0.760 |
Why?
| | Focal Adhesions | 1 | 2021 | 42 | 0.750 |
Why?
| | Fetofetal Transfusion | 1 | 2021 | 20 | 0.740 |
Why?
| | Heart Defects, Congenital | 4 | 2021 | 752 | 0.710 |
Why?
| | Biomarkers | 8 | 2024 | 3874 | 0.700 |
Why?
| | Extracellular Matrix | 2 | 2021 | 493 | 0.690 |
Why?
| | Cardiomegaly | 5 | 2015 | 172 | 0.670 |
Why?
| | Adenylyl Cyclases | 2 | 2016 | 83 | 0.630 |
Why?
| | Receptors, Adrenergic, beta-1 | 2 | 2011 | 47 | 0.620 |
Why?
| | Rats | 15 | 2021 | 5236 | 0.620 |
Why?
| | Signal Transduction | 11 | 2023 | 4857 | 0.620 |
Why?
| | Phosphodiesterase Inhibitors | 2 | 2016 | 85 | 0.620 |
Why?
| | Calcium | 2 | 2021 | 1173 | 0.590 |
Why?
| | Animals, Newborn | 8 | 2021 | 813 | 0.580 |
Why?
| | RNA, Long Noncoding | 1 | 2020 | 175 | 0.570 |
Why?
| | Protein Kinase C | 2 | 2011 | 258 | 0.570 |
Why?
| | Cardiomyopathies | 1 | 2021 | 333 | 0.560 |
Why?
| | Ventricular Function, Left | 3 | 2018 | 526 | 0.540 |
Why?
| | Specimen Handling | 1 | 2018 | 163 | 0.530 |
Why?
| | Adrenergic beta-Antagonists | 2 | 2017 | 320 | 0.530 |
Why?
| | Animals | 35 | 2024 | 34628 | 0.530 |
Why?
| | Plasma | 1 | 2018 | 198 | 0.520 |
Why?
| | Bleomycin | 5 | 2020 | 241 | 0.510 |
Why?
| | Exosomes | 1 | 2017 | 95 | 0.500 |
Why?
| | Child | 23 | 2022 | 20824 | 0.500 |
Why?
| | Ventricular Myosins | 3 | 2005 | 36 | 0.500 |
Why?
| | Real-Time Polymerase Chain Reaction | 5 | 2017 | 326 | 0.480 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2020 | 816 | 0.480 |
Why?
| | Transcription Factors | 7 | 2016 | 1634 | 0.480 |
Why?
| | Cyclic AMP | 5 | 2019 | 230 | 0.470 |
Why?
| | Connexin 43 | 2 | 2012 | 24 | 0.470 |
Why?
| | Cells, Cultured | 14 | 2019 | 4048 | 0.470 |
Why?
| | Down-Regulation | 6 | 2021 | 637 | 0.460 |
Why?
| | Humans | 55 | 2024 | 128896 | 0.460 |
Why?
| | Child, Preschool | 16 | 2021 | 10457 | 0.440 |
Why?
| | Adrenergic beta-1 Receptor Antagonists | 1 | 2013 | 11 | 0.430 |
Why?
| | Gene Expression | 7 | 2017 | 1476 | 0.430 |
Why?
| | Polymorphism, Genetic | 2 | 2019 | 641 | 0.430 |
Why?
| | Superoxide Dismutase | 3 | 2020 | 328 | 0.420 |
Why?
| | Heart Transplantation | 4 | 2016 | 713 | 0.410 |
Why?
| | Myosin Heavy Chains | 4 | 2014 | 173 | 0.410 |
Why?
| | Heart | 4 | 2021 | 650 | 0.410 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 3 | 2012 | 181 | 0.410 |
Why?
| | Female | 37 | 2024 | 68162 | 0.400 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2012 | 45 | 0.400 |
Why?
| | DNA-Binding Proteins | 5 | 2005 | 1423 | 0.380 |
Why?
| | Adrenergic beta-1 Receptor Agonists | 1 | 2011 | 5 | 0.370 |
Why?
| | Sex Characteristics | 3 | 2019 | 722 | 0.370 |
Why?
| | Mitochondria, Heart | 3 | 2024 | 93 | 0.370 |
Why?
| | Male | 35 | 2024 | 63146 | 0.370 |
Why?
| | Receptors, Adrenergic, alpha-1 | 1 | 2011 | 44 | 0.360 |
Why?
| | Recovery of Function | 1 | 2015 | 641 | 0.360 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 134 | 0.340 |
Why?
| | RNA | 1 | 2016 | 877 | 0.330 |
Why?
| | Heart Diseases | 1 | 2013 | 356 | 0.330 |
Why?
| | Isoproterenol | 3 | 2018 | 111 | 0.320 |
Why?
| | Gene Expression Profiling | 6 | 2021 | 1694 | 0.310 |
Why?
| | Myocardial Infarction | 2 | 2018 | 1031 | 0.310 |
Why?
| | Milrinone | 2 | 2021 | 29 | 0.310 |
Why?
| | Adaptation, Physiological | 1 | 2012 | 516 | 0.300 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2 | 2021 | 40 | 0.300 |
Why?
| | Cardiac Output, Low | 2 | 2021 | 66 | 0.290 |
Why?
| | Myocardial Contraction | 3 | 2019 | 336 | 0.280 |
Why?
| | Cardiolipins | 2 | 2020 | 81 | 0.270 |
Why?
| | Myocardial Ischemia | 1 | 2008 | 254 | 0.260 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2006 | 67 | 0.260 |
Why?
| | Case-Control Studies | 6 | 2024 | 3334 | 0.260 |
Why?
| | Lung Injury | 2 | 2018 | 214 | 0.250 |
Why?
| | Mice | 13 | 2024 | 16543 | 0.250 |
Why?
| | Rats, Sprague-Dawley | 3 | 2021 | 2308 | 0.250 |
Why?
| | Mice, Inbred C57BL | 7 | 2024 | 5270 | 0.240 |
Why?
| | Inflammation | 4 | 2020 | 2694 | 0.240 |
Why?
| | Infant | 9 | 2020 | 8994 | 0.240 |
Why?
| | Antigens, Nuclear | 1 | 2004 | 20 | 0.240 |
Why?
| | Protein Kinases | 1 | 2006 | 305 | 0.230 |
Why?
| | Disease Models, Animal | 7 | 2024 | 3994 | 0.220 |
Why?
| | Echocardiography | 2 | 2021 | 634 | 0.220 |
Why?
| | Fetal Heart | 1 | 2024 | 53 | 0.220 |
Why?
| | Age Factors | 6 | 2018 | 3133 | 0.210 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 3 | 2014 | 175 | 0.210 |
Why?
| | Sarcomeres | 1 | 2023 | 92 | 0.200 |
Why?
| | Caloric Restriction | 1 | 2024 | 108 | 0.200 |
Why?
| | Glutathione | 1 | 2024 | 333 | 0.200 |
Why?
| | Fetal Blood | 1 | 2024 | 315 | 0.200 |
Why?
| | Endopeptidase K | 1 | 2021 | 15 | 0.190 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2024 | 204 | 0.190 |
Why?
| | Receptor, EphA2 | 2 | 2018 | 19 | 0.190 |
Why?
| | Ribonucleases | 1 | 2021 | 53 | 0.190 |
Why?
| | Adult | 11 | 2024 | 35361 | 0.190 |
Why?
| | Light Coagulation | 1 | 2021 | 7 | 0.190 |
Why?
| | Fetal Growth Retardation | 2 | 2024 | 542 | 0.190 |
Why?
| | Fetoscopy | 1 | 2021 | 27 | 0.190 |
Why?
| | Serum Response Factor | 1 | 2021 | 30 | 0.190 |
Why?
| | Mice, Transgenic | 3 | 2023 | 2073 | 0.190 |
Why?
| | Oligonucleotide Array Sequence Analysis | 3 | 2013 | 772 | 0.180 |
Why?
| | Mutation | 4 | 2023 | 3671 | 0.180 |
Why?
| | Phenotype | 5 | 2023 | 3059 | 0.180 |
Why?
| | Microscopy, Atomic Force | 1 | 2021 | 114 | 0.180 |
Why?
| | Drainage | 1 | 2021 | 162 | 0.170 |
Why?
| | Prospective Studies | 6 | 2024 | 7060 | 0.170 |
Why?
| | Biological Products | 1 | 2023 | 202 | 0.170 |
Why?
| | Cluster Analysis | 1 | 2021 | 479 | 0.170 |
Why?
| | Extracellular Fluid | 1 | 2019 | 31 | 0.160 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 88 | 0.160 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2019 | 10 | 0.160 |
Why?
| | Ultrasonography, Prenatal | 1 | 2021 | 266 | 0.160 |
Why?
| | Chromosome Fragility | 1 | 1999 | 2 | 0.160 |
Why?
| | Apoptosis | 2 | 2019 | 2481 | 0.160 |
Why?
| | Natriuretic Peptide, Brain | 2 | 2012 | 101 | 0.160 |
Why?
| | Ephrin-A2 | 1 | 2018 | 3 | 0.160 |
Why?
| | Troponin I | 1 | 2019 | 75 | 0.160 |
Why?
| | Trinucleotide Repeats | 1 | 1999 | 26 | 0.160 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 422 | 0.160 |
Why?
| | Fever | 1 | 2020 | 301 | 0.150 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2009 | 112 | 0.150 |
Why?
| | HEK293 Cells | 1 | 2021 | 673 | 0.150 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2018 | 22 | 0.150 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2021 | 420 | 0.150 |
Why?
| | Pharmacogenomic Testing | 1 | 2019 | 59 | 0.150 |
Why?
| | Energy Metabolism | 1 | 2024 | 837 | 0.150 |
Why?
| | Prognosis | 3 | 2018 | 3787 | 0.150 |
Why?
| | Cardiovascular Diseases | 1 | 2010 | 2013 | 0.150 |
Why?
| | Pregnancy | 4 | 2024 | 6247 | 0.150 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2018 | 95 | 0.150 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2020 | 2070 | 0.150 |
Why?
| | Myofibroblasts | 1 | 2019 | 132 | 0.150 |
Why?
| | Nerve Tissue Proteins | 2 | 2018 | 568 | 0.140 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 957 | 0.140 |
Why?
| | Freezing | 1 | 2018 | 86 | 0.140 |
Why?
| | Pilot Projects | 1 | 2022 | 1545 | 0.140 |
Why?
| | Kidney | 2 | 2024 | 1330 | 0.140 |
Why?
| | Blotting, Western | 3 | 2016 | 1188 | 0.140 |
Why?
| | Adolescent | 7 | 2021 | 20197 | 0.140 |
Why?
| | Myocarditis | 1 | 2018 | 101 | 0.140 |
Why?
| | Acute Lung Injury | 1 | 2020 | 278 | 0.140 |
Why?
| | G-Protein-Coupled Receptor Kinase 2 | 1 | 2016 | 11 | 0.140 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2019 | 168 | 0.140 |
Why?
| | Death, Sudden, Cardiac | 1 | 2018 | 179 | 0.140 |
Why?
| | Cell Size | 1 | 2017 | 86 | 0.140 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2017 | 78 | 0.130 |
Why?
| | Critical Illness | 1 | 2022 | 753 | 0.130 |
Why?
| | Acute Kidney Injury | 1 | 2024 | 786 | 0.130 |
Why?
| | Renin-Angiotensin System | 1 | 2017 | 80 | 0.130 |
Why?
| | Cardiotonic Agents | 2 | 2021 | 128 | 0.130 |
Why?
| | Macrophages, Alveolar | 1 | 2019 | 389 | 0.130 |
Why?
| | Ventricular Function, Right | 1 | 2018 | 274 | 0.130 |
Why?
| | Cell Line | 2 | 2021 | 2759 | 0.130 |
Why?
| | Transcription, Genetic | 5 | 2013 | 1408 | 0.130 |
Why?
| | Erythroid-Specific DNA-Binding Factors | 3 | 2005 | 18 | 0.130 |
Why?
| | Protein Binding | 4 | 2013 | 2086 | 0.130 |
Why?
| | Middle Aged | 10 | 2018 | 30977 | 0.130 |
Why?
| | Vascular Resistance | 1 | 2017 | 373 | 0.130 |
Why?
| | Up-Regulation | 2 | 2018 | 848 | 0.130 |
Why?
| | Metabolic Networks and Pathways | 1 | 2017 | 176 | 0.130 |
Why?
| | Arrhythmias, Cardiac | 1 | 2018 | 312 | 0.130 |
Why?
| | Receptors, Nicotinic | 1 | 2018 | 323 | 0.130 |
Why?
| | Stem Cell Transplantation | 1 | 2017 | 167 | 0.130 |
Why?
| | Sympathetic Nervous System | 1 | 2017 | 184 | 0.130 |
Why?
| | Liver | 1 | 2024 | 1832 | 0.120 |
Why?
| | Collagen Type III | 1 | 2015 | 15 | 0.120 |
Why?
| | RNA-Binding Proteins | 1 | 1999 | 382 | 0.120 |
Why?
| | Hot Temperature | 1 | 2018 | 362 | 0.120 |
Why?
| | DNA Primers | 3 | 2011 | 522 | 0.120 |
Why?
| | Transcriptional Activation | 2 | 2008 | 360 | 0.120 |
Why?
| | Electron Transport Complex IV | 1 | 1995 | 57 | 0.120 |
Why?
| | Lung | 4 | 2024 | 3925 | 0.120 |
Why?
| | Antibiotics, Antineoplastic | 3 | 2020 | 120 | 0.120 |
Why?
| | Nanoparticles | 1 | 2018 | 358 | 0.120 |
Why?
| | Cytoskeletal Proteins | 1 | 2015 | 141 | 0.120 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 1995 | 113 | 0.120 |
Why?
| | Cohort Studies | 3 | 2022 | 5394 | 0.110 |
Why?
| | Microfilament Proteins | 1 | 2015 | 130 | 0.110 |
Why?
| | Heart Rate | 1 | 2018 | 807 | 0.110 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2017 | 219 | 0.110 |
Why?
| | Hypertension, Pulmonary | 2 | 2017 | 1876 | 0.110 |
Why?
| | Stroke Volume | 1 | 2017 | 587 | 0.110 |
Why?
| | ROC Curve | 1 | 2015 | 500 | 0.110 |
Why?
| | Peptides | 1 | 2018 | 902 | 0.110 |
Why?
| | Biopsy | 1 | 2017 | 1093 | 0.100 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2767 | 0.100 |
Why?
| | Analysis of Variance | 2 | 2016 | 1283 | 0.100 |
Why?
| | Promoter Regions, Genetic | 3 | 2004 | 1194 | 0.100 |
Why?
| | Atrial Natriuretic Factor | 2 | 2016 | 56 | 0.100 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 822 | 0.100 |
Why?
| | Young Adult | 2 | 2021 | 12286 | 0.100 |
Why?
| | Nuclear Proteins | 1 | 2016 | 644 | 0.090 |
Why?
| | Endothelium, Vascular | 1 | 2018 | 917 | 0.090 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2014 | 226 | 0.090 |
Why?
| | Proto-Oncogene Proteins | 1 | 1995 | 636 | 0.090 |
Why?
| | Fibrosis | 3 | 2019 | 518 | 0.090 |
Why?
| | Glycine | 1 | 2011 | 162 | 0.090 |
Why?
| | Heart-Assist Devices | 1 | 2016 | 529 | 0.090 |
Why?
| | Organ Specificity | 1 | 2011 | 296 | 0.090 |
Why?
| | Arginine | 1 | 2011 | 254 | 0.080 |
Why?
| | Genotype | 2 | 2020 | 1834 | 0.080 |
Why?
| | Gene Regulatory Networks | 2 | 2023 | 278 | 0.080 |
Why?
| | Enzyme Activation | 1 | 2011 | 811 | 0.080 |
Why?
| | Cell Movement | 1 | 2013 | 932 | 0.080 |
Why?
| | PPAR alpha | 1 | 2008 | 58 | 0.080 |
Why?
| | Fibroblasts | 1 | 2013 | 946 | 0.080 |
Why?
| | Adenosine Monophosphate | 2 | 2021 | 62 | 0.080 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2009 | 289 | 0.070 |
Why?
| | Time Factors | 4 | 2018 | 6568 | 0.070 |
Why?
| | Heart Function Tests | 1 | 2008 | 61 | 0.070 |
Why?
| | Heat-Shock Proteins | 1 | 2008 | 128 | 0.070 |
Why?
| | Desmin | 1 | 2007 | 24 | 0.070 |
Why?
| | Computational Biology | 1 | 2011 | 587 | 0.070 |
Why?
| | Genetic Markers | 2 | 2018 | 335 | 0.070 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2006 | 7 | 0.070 |
Why?
| | Indole Alkaloids | 1 | 2006 | 9 | 0.070 |
Why?
| | Protein Phosphatase 2 | 1 | 2006 | 38 | 0.070 |
Why?
| | Cell Proliferation | 1 | 2013 | 2337 | 0.060 |
Why?
| | Carbazoles | 1 | 2006 | 84 | 0.060 |
Why?
| | Inflammation Mediators | 2 | 2019 | 503 | 0.060 |
Why?
| | Receptors, Estrogen | 1 | 2008 | 423 | 0.060 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2005 | 63 | 0.060 |
Why?
| | Aged | 6 | 2018 | 22035 | 0.060 |
Why?
| | Cytoplasm | 1 | 2006 | 260 | 0.060 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2005 | 78 | 0.060 |
Why?
| | Adrenergic beta-Agonists | 1 | 2006 | 132 | 0.060 |
Why?
| | Acute Coronary Syndrome | 1 | 2008 | 267 | 0.060 |
Why?
| | Ku Autoantigen | 1 | 2004 | 13 | 0.060 |
Why?
| | Calcium Channels, L-Type | 1 | 2006 | 114 | 0.060 |
Why?
| | Protein Transport | 1 | 2006 | 423 | 0.060 |
Why?
| | 3' Untranslated Regions | 2 | 2016 | 137 | 0.060 |
Why?
| | Pregnancy Trimester, Third | 1 | 2024 | 105 | 0.060 |
Why?
| | Citrate (si)-Synthase | 1 | 2024 | 58 | 0.060 |
Why?
| | Cell Respiration | 1 | 2024 | 92 | 0.060 |
Why?
| | Infant, Newborn | 3 | 2024 | 5704 | 0.060 |
Why?
| | Protein Structure, Tertiary | 1 | 2006 | 832 | 0.050 |
Why?
| | Actins | 1 | 2006 | 403 | 0.050 |
Why?
| | Receptors, Adrenergic | 1 | 2023 | 35 | 0.050 |
Why?
| | Suppression, Genetic | 1 | 2003 | 24 | 0.050 |
Why?
| | Oxidative Phosphorylation | 1 | 2024 | 184 | 0.050 |
Why?
| | Prenatal Diagnosis | 1 | 2024 | 189 | 0.050 |
Why?
| | Haplotypes | 2 | 2018 | 473 | 0.050 |
Why?
| | Glycolysis | 1 | 2024 | 295 | 0.050 |
Why?
| | Mutagenesis | 1 | 2003 | 178 | 0.050 |
Why?
| | Gene Deletion | 1 | 2003 | 374 | 0.050 |
Why?
| | Sheep | 1 | 2024 | 832 | 0.050 |
Why?
| | Metabolome | 1 | 2024 | 316 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2019 | 3042 | 0.050 |
Why?
| | Ischemia | 1 | 2024 | 396 | 0.050 |
Why?
| | Lipid Metabolism | 1 | 2024 | 491 | 0.040 |
Why?
| | Linear Models | 2 | 2016 | 817 | 0.040 |
Why?
| | Triggering Receptor Expressed on Myeloid Cells-1 | 1 | 2020 | 7 | 0.040 |
Why?
| | RAW 264.7 Cells | 1 | 2020 | 48 | 0.040 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2020 | 131 | 0.040 |
Why?
| | Metabolomics | 1 | 2024 | 592 | 0.040 |
Why?
| | Disease Progression | 1 | 2007 | 2603 | 0.040 |
Why?
| | Transfection | 2 | 2007 | 904 | 0.040 |
Why?
| | X Chromosome | 1 | 1999 | 51 | 0.040 |
Why?
| | Minisatellite Repeats | 1 | 1999 | 40 | 0.040 |
Why?
| | Brazil | 1 | 1999 | 100 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2006 | 1854 | 0.040 |
Why?
| | Flecainide | 1 | 2018 | 7 | 0.040 |
Why?
| | DNA, Mitochondrial | 1 | 2020 | 194 | 0.040 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2018 | 37 | 0.040 |
Why?
| | Fragile X Mental Retardation Protein | 1 | 1999 | 55 | 0.040 |
Why?
| | Cell Membrane Permeability | 1 | 2018 | 82 | 0.040 |
Why?
| | Protective Factors | 1 | 2018 | 90 | 0.040 |
Why?
| | Guinea Pigs | 1 | 2018 | 158 | 0.040 |
Why?
| | Fragile X Syndrome | 1 | 1999 | 73 | 0.040 |
Why?
| | Ryanodine Receptor Calcium Release Channel | 1 | 2018 | 60 | 0.040 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2018 | 110 | 0.040 |
Why?
| | Oxidative Stress | 1 | 2024 | 1220 | 0.040 |
Why?
| | DNA | 1 | 2004 | 1406 | 0.040 |
Why?
| | Genetics, Population | 1 | 1999 | 200 | 0.040 |
Why?
| | Placenta | 1 | 2024 | 706 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2019 | 305 | 0.040 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2016 | 17 | 0.030 |
Why?
| | Inflammasomes | 1 | 2018 | 128 | 0.030 |
Why?
| | Galectin 3 | 1 | 2016 | 19 | 0.030 |
Why?
| | Sampling Studies | 1 | 2016 | 95 | 0.030 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2016 | 55 | 0.030 |
Why?
| | Cell Cycle | 1 | 2019 | 581 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2018 | 356 | 0.030 |
Why?
| | Transcription Elongation, Genetic | 1 | 2016 | 22 | 0.030 |
Why?
| | Transcription Initiation Site | 1 | 2016 | 43 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2018 | 376 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2016 | 306 | 0.030 |
Why?
| | Acetylation | 1 | 2016 | 235 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2019 | 728 | 0.030 |
Why?
| | Aortic Valve | 1 | 2019 | 425 | 0.030 |
Why?
| | GA-Binding Protein Transcription Factor | 1 | 1995 | 5 | 0.030 |
Why?
| | Action Potentials | 1 | 2018 | 463 | 0.030 |
Why?
| | Reference Values | 1 | 2016 | 791 | 0.030 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1995 | 131 | 0.030 |
Why?
| | 3T3 Cells | 1 | 1995 | 151 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 1995 | 52 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2018 | 1013 | 0.030 |
Why?
| | Exons | 1 | 1995 | 330 | 0.030 |
Why?
| | DNA, Complementary | 1 | 1995 | 270 | 0.030 |
Why?
| | Base Sequence | 2 | 1995 | 2157 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1995 | 356 | 0.030 |
Why?
| | Polypyrimidine Tract-Binding Protein | 1 | 2013 | 16 | 0.030 |
Why?
| | Tissue Donors | 1 | 2016 | 398 | 0.030 |
Why?
| | Plasmids | 1 | 1995 | 357 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 71 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 1995 | 503 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 1995 | 2842 | 0.030 |
Why?
| | Receptor, Notch1 | 1 | 2013 | 62 | 0.030 |
Why?
| | Chemokine CCL2 | 1 | 2013 | 122 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2013 | 114 | 0.030 |
Why?
| | RNA Polymerase II | 1 | 2016 | 313 | 0.030 |
Why?
| | HeLa Cells | 1 | 1995 | 602 | 0.030 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2013 | 197 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 182 | 0.030 |
Why?
| | Chromatin | 1 | 2016 | 470 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 2016 | 576 | 0.030 |
Why?
| | Hydrogels | 1 | 2019 | 634 | 0.020 |
Why?
| | Interleukin-1 | 1 | 2016 | 972 | 0.020 |
Why?
| | Rats, Wistar | 1 | 2013 | 396 | 0.020 |
Why?
| | Mitochondrial Proteins | 1 | 2014 | 234 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1840 | 0.020 |
Why?
| | Exercise | 1 | 2003 | 1923 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2018 | 2770 | 0.020 |
Why?
| | Binding Sites | 1 | 1995 | 1238 | 0.020 |
Why?
| | Cattle | 1 | 2013 | 970 | 0.020 |
Why?
| | Macrophages | 1 | 2018 | 1452 | 0.020 |
Why?
| | MADS Domain Proteins | 1 | 2009 | 5 | 0.020 |
Why?
| | Registries | 2 | 2008 | 1916 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 2270 | 0.020 |
Why?
| | Myogenic Regulatory Factors | 1 | 2009 | 56 | 0.020 |
Why?
| | MEF2 Transcription Factors | 1 | 2009 | 62 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 2008 | 45 | 0.020 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2008 | 42 | 0.020 |
Why?
| | Genes | 1 | 2008 | 226 | 0.020 |
Why?
| | Homozygote | 1 | 2008 | 192 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 165 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2008 | 298 | 0.020 |
Why?
| | Heterozygote | 1 | 2008 | 268 | 0.020 |
Why?
| | Pulmonary Artery | 1 | 2013 | 1091 | 0.020 |
Why?
| | Genetic Carrier Screening | 1 | 2007 | 25 | 0.020 |
Why?
| | Gene Frequency | 1 | 2008 | 503 | 0.020 |
Why?
| | Risk Assessment | 1 | 2016 | 3286 | 0.020 |
Why?
| | Drug Interactions | 1 | 2008 | 370 | 0.020 |
Why?
| | Genes, Dominant | 1 | 2007 | 92 | 0.020 |
Why?
| | United States | 2 | 2018 | 13975 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2009 | 569 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2007 | 404 | 0.020 |
Why?
| | Risk Factors | 1 | 2018 | 9792 | 0.010 |
Why?
| | Genetic Testing | 1 | 2007 | 424 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2005 | 539 | 0.010 |
Why?
| | Mitochondria | 1 | 2008 | 837 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2005 | 1304 | 0.010 |
Why?
| | Prevalence | 1 | 2007 | 2540 | 0.010 |
Why?
| | Hospitalization | 1 | 2008 | 2080 | 0.010 |
Why?
| | Single-Strand Specific DNA and RNA Endonucleases | 1 | 1995 | 10 | 0.010 |
Why?
| | Restriction Mapping | 1 | 1995 | 77 | 0.010 |
Why?
| | TATA Box | 1 | 1995 | 24 | 0.010 |
Why?
| | Deoxyribonuclease I | 1 | 1995 | 37 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1995 | 202 | 0.010 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 1995 | 88 | 0.010 |
Why?
| | Genes, Reporter | 1 | 1995 | 268 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2008 | 10239 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1995 | 928 | 0.010 |
Why?
| | Carcinoma, Hepatocellular | 1 | 1995 | 267 | 0.010 |
Why?
|
|
Sucharov's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|